BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu ZR, Zhang YM, Cui ZL, Tong W. Effects of thrombopoietin pre-treatment on peri-liver transplantation thrombocytopenia in a mouse model of cirrhosis with hypersplenism. World J Gastrointest Surg 2023; 15(10): 2115-2122 [PMID: 37969704 DOI: 10.4240/wjgs.v15.i10.2115]
URL: https://www.wjgnet.com/1948-9366/full/v15/i10/2115.htm
Number Citing Articles
1
Ting Jin, Qifeng Jin, Yonghong Hua, Shuang Huang, Xiaozhong Chen. Recombinant Human Thrombopoietin Combined With Avatrombopag for Chemoradiotherapy-Induced Thrombocytopenia in Nasopharyngeal Carcinoma: A Prospective, Randomized Controlled TrialBritish Journal of Hospital Medicine 2025; 86(9): 1 doi: 10.12968/hmed.2025.0641
2
Zu-yu Wang, Xiao-an Liu, Jun-peng Jian, Han-xuan Wang, Shao-cheng Lyu, Zhu Meng, Ren Lang. Multimodal clinical–imaging deep learning model for predicting refractory hypersplenism after liver transplantationScientific Reports 2026;  doi: 10.1038/s41598-026-48940-2
3
A. V. Shabunin, Z. A. Bagateliya, Ch. S. Pavlov, P. A. Drozdov, O. N. Levina, S. V. Osipova, V. A. Tsurkan, S. A. Astapovich, E. А. Lidzhieva, G. S. Mikhaylyant, D. V. Matveev. Thrombocytopenia in liver cirrhosis: efficacy of eltrombopag and partial splenic artery embolization in determining optimal treatment indicationsTransplantologiya. The Russian Journal of Transplantation 2026; 18(1): 22 doi: 10.23873/2074-0506-2026-18-1-22-31